We are all an important part of research. Research helps us understand the world around us, including why people get sick and how to develop treatments and therapies to help them get better. Most of the medical treatments available today are possible thanks to previous clinical trials.
Racial and ethnic minorities, people with disabilities, the LGBTQ community, and other underrepresented groups are of special interest in the clinical trials space.
Your participation is critical in clinical studies because drug response in different diseases can vary significantly between men and women, between younger or older adults, and between different races and ethnic groups.
By participating in clinical studies, you can help determine if a medicine, vaccine, treatment, or behavioral therapy works for individuals like you in age, gender, occupation, nationality, ethnic background, or sexual orientation.
SiteBridge Research recognizes that you may face some hurdles that make it difficult to participate in a clinical trial. We address those obstacles head on to make participation possible for you, your family members, or friends. When allowed by the trial sponsors, we plan to provide the following:
We make it easier for you to participate.
Clinical trials are research studies in which people volunteer to help find the answers to specific health questions. Participation in these studies is always voluntary.
Safety is a priority in clinical studies. Researchers must follow detailed guidelines (eligibility protocols) to ensure each study is as safe as possible. Before you agree to join a clinical trial, the study will be explained to you in an informed consent process.
People from different gender, age, racial and ethnic backgrounds may react differently to the same treatments. For example, African Americans sometimes need a different dosage than Asian, Hispanics or whites for certain blood pressure or asthma medications. For this reason, the inclusion of diverse people in clinical research will leads to an improved quality of life.